Helping You Translate Inspiration into Bold Scientific Strategy, Impact, and Innovation
As a research scientist and academic leader, I specialize in turning bold scientific ideas into fundable, well-executed, and strategically aligned research programs. My consulting services bridge molecular biology, biomedical engineering, and scientific communication to help R&D teams, biotech innovators, and academic institutions bring complex ideas to life with clarity, rigor, and translational focus.
Whether you’re developing a synthetic biology platform, launching a novel research direction, or preparing a grant or investor pitch, I offer deep domain expertise and a proven track record of guiding high-impact projects from concept to success.
Areas of Expertise
Chromatin complexes and histone modification systems in human and other mammalian cells
Synthetic biology: RNA tools, fusion protein engineering, gene expression control
Long noncoding RNAs (lncRNAs) as therapeutic tools and research platforms
Research proposal design (NIH, NSF, foundations) and review readiness
Scientific communication for high-impact publications and funding presentations
Strategic advising for early-stage biotech startups or cross-institutional research teams
Who I Work With
Biotech & Pharma Teams: Scientific strategy and validation for chromatin/RNA-based tools or therapeutic platforms
Startups: Translational research planning, proposal development, and narrative framing for investor decks
Academic Labs & Institutions: External proposal reviews, manuscript development
Research Networks: Speaker, panelist, and advisor for DEI in STEM, emerging technologies, and synthetic biology education
Why Work With Me
With over $5 million in research funding secured and more than 30 publications across synthetic biology, epigenetics, and gene regulation, I bring both technical depth and strategic foresight to every project. I’ve served on review panels for NIH, NSF, the American Cancer Society, and international funders, and I understand what makes research ideas fundable, scalable, and impactful.
Dr. Karmella Haynes 